Detailed electrochemical studies in dichloromethane (0.1 M Bu 4NPF6) on the oxidation of the half-lantern [Pt 2(κ2As,C-C6H3-5-Me-2-AsPh 2)2(μ-κAs,κC-C6H 3-5-Me-2-AsPh2)2] (1) and full-lantern [Pt 2(μ-κAs,κC-C6H3-5-Me-2-AsPh 2)4] (2) complexes reve
Electrochemical studies of the salts [cat] 4[Pt 2(μ-pop) 4] (cat + = Bu 4N + or PPN + [Ph 3P=N=PPh 3...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Detailed electrochemical studies in dichloromethane (0.1 M BU4NPF6) on the oxidation of the half-lan...
Reaction of 2-Li-4-MeC6H3AsPh2 with [PtCl2(SEt2)2] gives two isomeric dinuclear platinum(II) complex...
The half-lantern compound [{Pt(bzq)(μ-C<sub>7</sub>H<sub>4</sub>NS<sub>2</sub>-κN,S)}<sub>2</sub>]...
A detailed study of the chemical and electrochemical oxidation of a platinum(II) organoamide complex...
Reaction of 2-Li-4-MeC6H3AsPh2 with [PtCl2(SEt2)2] gives two isomeric dinuclear platinum(II) complex...
η3-Allyl complexes of the type [M(η3-allyl)(L2)]+ (M Pd; allyl = 1-MeC3H4; L2 = 1,5-C8H12, 2MeCN; al...
Electrochemical studies of the salts [cat]4[Pt2(μ-pop)4] (cat+ = Bu4N+ or PPN+ [Ph3PNPPh3]+; pop = p...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
The evolution in basic medium ([RO-] = 1 M in methanol, R = H or Me) of five-coordinate platinum(II)...
Characterization of the anticancer active compound trans-[Pt{(p-BrCF)NCHCHNEt}Cl(py)] is described a...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Electrochemical studies of the salts [cat] 4[Pt 2(μ-pop) 4] (cat + = Bu 4N + or PPN + [Ph 3P=N=PPh 3...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Detailed electrochemical studies in dichloromethane (0.1 M BU4NPF6) on the oxidation of the half-lan...
Reaction of 2-Li-4-MeC6H3AsPh2 with [PtCl2(SEt2)2] gives two isomeric dinuclear platinum(II) complex...
The half-lantern compound [{Pt(bzq)(μ-C<sub>7</sub>H<sub>4</sub>NS<sub>2</sub>-κN,S)}<sub>2</sub>]...
A detailed study of the chemical and electrochemical oxidation of a platinum(II) organoamide complex...
Reaction of 2-Li-4-MeC6H3AsPh2 with [PtCl2(SEt2)2] gives two isomeric dinuclear platinum(II) complex...
η3-Allyl complexes of the type [M(η3-allyl)(L2)]+ (M Pd; allyl = 1-MeC3H4; L2 = 1,5-C8H12, 2MeCN; al...
Electrochemical studies of the salts [cat]4[Pt2(μ-pop)4] (cat+ = Bu4N+ or PPN+ [Ph3PNPPh3]+; pop = p...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
The evolution in basic medium ([RO-] = 1 M in methanol, R = H or Me) of five-coordinate platinum(II)...
Characterization of the anticancer active compound trans-[Pt{(p-BrCF)NCHCHNEt}Cl(py)] is described a...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Electrochemical studies of the salts [cat] 4[Pt 2(μ-pop) 4] (cat + = Bu 4N + or PPN + [Ph 3P=N=PPh 3...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...
Characterization of the anticancer active compound trans-[PtII{(p-BrC6F4)NCH2CH2NEt2}Cl(py)] is desc...